The Association of Indian Medical Device Industry
(AiMeD) has called for stricter monitoring of the maximum retail price (MRP) of
imported medical devices in India to ensure affordability for Indian consumers.
In its pre-budget memorandum to the Finance Ministry, AiMeD highlighted that
while the government’s efforts to reduce import duties on medical devices aim
to lower costs, consumers are still paying 10 to 30 times the import landed
price.
AiMeD has urged the government to withdraw
concessional duty notifications that reduce import duties to 0 to 7.5%, advocating
instead for a revised tariff structure of 5 to 15% on medical devices. According
to Rajiv Nath, Forum Coordinator of AiMeD, such measures are necessary to
promote domestic manufacturing and align with the “Make in India” initiative.
“Despite promises made in earlier Budget speeches, NIL
and concessional duty exemptions continue to disadvantage Indian manufacturers,
forcing many to turn into import traders. A predictable tariff policy with
nominal protection is essential for fostering domestic production,” said Nath in a recent letter to Finance Minister Nirmala Sitharaman.
Challenges
Facing Indian Manufacturers
India’s medical device industry has faced consistent
challenges, including:
High
Import Dependency: Over 70% of medical devices are imported,
with imports exceeding Rs. 69,000 Crores in 2023-24—a 13% increase from the
previous fiscal year.
Unfavorable
Duty Structures: The current 0-7.5% basic import tariff,
combined with GST benefits for importers, puts Indian manufacturers at a
competitive disadvantage.
Manufacturing
Disabilities: Indigenous manufacturers face a 12 to 15%
cost disability due to factors like high infrastructure costs, limited R&D
capabilities, and inadequate power supply.
AiMeD's
Recommendations
To curb the growing reliance on imports and support
domestic manufacturers, AiMeD has proposed the following measures:
Increase
Import Tariffs: Raise basic import duties to 5-15% for
finished devices and at least 5-7.5% for components.
Retain
Low Duty on Raw Materials: Maintain a 2.5% concessional duty on
raw materials and packaging for three more years to support local production.
Withdraw
NIL Duty Notifications: Remove duty exemptions that
undermine Indian manufacturing competitiveness.
Create
a Favorable Ecosystem: Provide support similar to the mobile
phone industry to nurture startups, MSMEs, and larger domestic manufacturers.
Impact
on “Make in India”
AiMeD stressed that a robust domestic industry could
adequately cater to the needs of India’s 1.4 billion population while reducing
the country’s reliance on imports. The group emphasized that nominal tariff
protection would incentivize manufacturers to expand capacity, enable exports,
and create employment.
The association also pointed out the unintended
consequences of the current duty structure. After the introduction of GST,
imported devices became 11% cheaper, making it harder for domestic
manufacturers to compete, especially in government tenders.
To address these disparities, AiMeD has requested the
government to implement fair trade policies that protect ethical manufacturers
and ensure medical security for India. By taking these steps, the government
can not only strengthen India’s medical device industry but also make quality
healthcare more accessible and affordable for its citizens.
AiMeD is an Umbrella Association of Indian
Manufacturers of Medical Devices covering all types of Medical Devices
including Consumables, Disposables, Equipments, Instruments, Electronics,
Diagnostics and Implants. With a Primary
Membership of over 300 Manufacturers and additionally of over 200 Associate
Members representing the interest of over 1200 Manufacturers of Medical Devices
to address the manufacturer’s problems.
The aim behind forming AiMeD is allow the Indian Government to access a
single point of contact and provide various services to the manufacturers like
Advocacy on policy issues, Information services, Regulations for Medical
Devices, Education and Training, services, Testing Assistance and guidance for
Quality Certification (ISO, CE, GMP), Lobbying for funding for R&D from the
Government, encourage innovations from member units, Improve clinician and
patient access to the modern, innovative and reliable Medical Device
technologies through organizing and supporting Meeting, Seminars, Symposia,
Exhibitions and Demonstrations and also, to promote global harmonization and
respect for the Indian Device Industry.
No comments:
Post a Comment